Based on stringent inclusion criteria, including targeted drug resistance in HER2+ breast cancer, miRNA expression data availability, and limited to human studies, 61 datasets were excluded, leaving us with three miRNA datasets (GSE47011, GSE197822, and GSE101841) for further analysis. The gene discussed is ERBB2; the disease is breast carcinoma.